Pharma Stability: Insights, Guidelines, and Expertise
SOP for Managing Stability Testing of Post-Approval Changes According to US FDA Guidelines Standard Operating Procedure for Stability Testing Following Post-Approval Changes 1) Purpose The purpose of this SOP is to provide a standardized approach for managing stability testing following post-approval changes to drug substances and products in compliance with US FDA guidelines.
SOP for Applying ICH Q1C Guidelines for Stability Testing of New Dosage Forms Standard Operating Procedure for Stability Testing of New Dosage Forms as per ICH Q1C 1) Purpose The purpose of this SOP is to provide a standardized procedure for conducting stability testing of new dosage forms in compliance with ICH Q1C guidelines to…
Read More “SOP for Applying ICH Q1C Guidelines for Stability Testing of New Dosage Forms” »
SOP for Developing Stability Study Reports for ANDA Submissions Standard Operating Procedure for Preparing Stability Reports for ANDAs 1) Purpose The purpose of this SOP is to provide a standardized procedure for developing stability study reports for Abbreviated New Drug Applications (ANDAs) to the US FDA, ensuring compliance with regulatory requirements. 2) Scope This SOP…
Read More “SOP for Developing Stability Study Reports for ANDA Submissions” »
SOP for Documenting Stability Studies for New Drug Applications (NDAs) to the US FDA Standard Operating Procedure for Stability Study Documentation for NDAs 1) Purpose The purpose of this SOP is to provide a standardized procedure for documenting stability studies in support of New Drug Applications (NDAs) to the US FDA to ensure compliance with…
Read More “SOP for Documenting Stability Studies for New Drug Applications (NDAs) to the US FDA” »
SOP for Conducting Stability Studies for Modified Release Products per FDA and ICH Guidelines Standard Operating Procedure for Stability Testing of Modified Release Products 1) Purpose The purpose of this SOP is to provide a standardized approach for conducting stability studies for modified-release products in compliance with US FDA and ICH guidelines to ensure their…
SOP for Designing Stability Studies for Combination Products as per Regulatory Guidelines Standard Operating Procedure for Stability Testing of Combination Products 1) Purpose The purpose of this SOP is to establish a procedure for designing stability studies for combination products, such as drug-device combinations, in compliance with applicable regulatory guidelines to ensure their safety, efficacy,…
SOP for Implementing ICH Q1E for Stability Data Evaluation Standard Operating Procedure for Stability Data Evaluation Following ICH Q1E 1) Purpose The purpose of this SOP is to provide a standardized procedure for evaluating stability data in compliance with ICH Q1E guidelines to ensure the quality, safety, and efficacy of drug substances and products throughout…
Read More “SOP for Implementing ICH Q1E for Stability Data Evaluation” »
SOP for Conducting Stability Studies for Drug Substances Under US FDA Guidelines Standard Operating Procedure for Stability Testing of Drug Substances According to FDA Guidelines 1) Purpose The purpose of this SOP is to outline the procedure for conducting stability studies for drug substances in compliance with US FDA guidelines to ensure their quality, safety,…
Read More “SOP for Conducting Stability Studies for Drug Substances Under US FDA Guidelines” »
SOP for Developing a Stability-Indicating Method in Compliance with ICH Q2(R1) Standard Operating Procedure for Creating a Stability-Indicating Method Following ICH Q2(R1) 1) Purpose The purpose of this SOP is to provide a standardized procedure for developing a stability-indicating analytical method that complies with ICH Q2(R1) guidelines to ensure the accuracy, precision, and reliability of…
Read More “SOP for Developing a Stability-Indicating Method in Compliance with ICH Q2(R1)” »
SOP for Addressing Stability Issues in ANDA Submissions to the US FDA Standard Operating Procedure for Handling Stability Issues in ANDA Submissions 1) Purpose The purpose of this SOP is to establish a procedure for addressing stability issues in Abbreviated New Drug Applications (ANDA) submissions to the US FDA to ensure compliance with regulatory requirements….
Read More “SOP for Addressing Stability Issues in ANDA Submissions to the US FDA” »